These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31870439)

  • 1. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
    Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
    Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.
    Arrant AE; Onyilo VC; Unger DE; Roberson ED
    J Neurosci; 2018 Feb; 38(9):2341-2358. PubMed ID: 29378861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
    Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
    Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.
    Arrant AE; Filiano AJ; Patel AR; Hoffmann MQ; Boyle NR; Kashyap SN; Onyilo VC; Young AH; Roberson ED
    Neurobiol Dis; 2019 Apr; 124():152-162. PubMed ID: 30448285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.
    Valdez C; Ysselstein D; Young TJ; Zheng J; Krainc D
    Hum Mol Genet; 2020 Mar; 29(5):716-726. PubMed ID: 31600775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
    Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
    J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
    Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
    Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
    Holler CJ; Taylor G; Deng Q; Kukar T
    eNeuro; 2017; 4(4):. PubMed ID: 28828399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.
    Arrant AE; Filiano AJ; Unger DE; Young AH; Roberson ED
    Brain; 2017 May; 140(5):1447-1465. PubMed ID: 28379303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
    Ward ME; Chen R; Huang HY; Ludwig C; Telpoukhovskaia M; Taubes A; Boudin H; Minami SS; Reichert M; Albrecht P; Gelfand JM; Cruz-Herranz A; Cordano C; Alavi MV; Leslie S; Seeley WW; Miller BL; Bigio E; Mesulam MM; Bogyo MS; Mackenzie IR; Staropoli JF; Cotman SL; Huang EJ; Gan L; Green AJ
    Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.
    Arrant AE; Davis SE; Vollmer RM; Murchison CF; Mobley JA; Nana AL; Spina S; Grinberg LT; Karydas AM; Miller BL; Seeley WW; Roberson ED
    Ann Clin Transl Neurol; 2020 Dec; 7(12):2433-2449. PubMed ID: 33197149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
    Khrouf W; Saracino D; Rucheton B; Houot M; Clot F; Rinaldi D; Vitor J; Huynh M; Heng E; Schlemmer D; Pasquier F; Deramecourt V; Auriacombe S; Azuar C; Levy R; Bombois S; Boutoleau-Brétonnière C; Pariente J; Didic M; Wallon D; Fluchère F; Auvin S; Younes IB; ; ; Nadjar Y; Brice A; Dubois B; Bonnefont-Rousselot D; Le Ber I; Lamari F
    Neurobiol Dis; 2023 Jun; 181():106108. PubMed ID: 37003407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
    Kashyap SN; Boyle NR; Roberson ED
    Neurotherapeutics; 2023 Jan; 20(1):140-153. PubMed ID: 36781744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
    Huin V; Barbier M; Bottani A; Lobrinus JA; Clot F; Lamari F; Chat L; Rucheton B; Fluchère F; Auvin S; Myers P; Gelot A; Camuzat A; Caillaud C; Jornéa L; Forlani S; Saracino D; Duyckaerts C; Brice A; Durr A; Le Ber I
    Brain; 2020 Jan; 143(1):303-319. PubMed ID: 31855245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin deficiency leads to reduced glucocerebrosidase activity.
    Zhou X; Paushter DH; Pagan MD; Kim D; Nunez Santos M; Lieberman RL; Overkleeft HS; Sun Y; Smolka MB; Hu F
    PLoS One; 2019; 14(7):e0212382. PubMed ID: 31291241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice.
    Frew J; Nygaard HB
    Acta Neuropathol Commun; 2021 Apr; 9(1):57. PubMed ID: 33795008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia.
    Simon MJ; Logan T; DeVos SL; Di Paolo G
    Trends Cell Biol; 2023 Apr; 33(4):324-339. PubMed ID: 36244875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic spine head diameter is reduced in the prefrontal cortex of progranulin haploinsufficient mice.
    Cook AK; Greathouse KM; Manuel PN; Cooper NH; Eberhardt JM; Freeman CD; Weber AJ; Herskowitz JH; Arrant AE
    Mol Brain; 2024 Jun; 17(1):33. PubMed ID: 38840181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.